A SNIPpet of safety: a Goldilocks approach in CAR-T therapy

Cell Res. 2022 Jul;32(7):603-604. doi: 10.1038/s41422-022-00682-2.

Mehdi Benzaoui^{1

2}, Naomi Taylor^{3

4}, Nirali N Shah⁵

¹ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France.
³ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. taylorn4@mail.nih.gov.
⁴ Institut de Génétique Moléculaire de Montpellier, Univ Montpellier, CNRS, Montpellier, France. taylorn4@mail.nih.gov.
⁵ Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. nirali.shah@mail.nih.gov.

No abstract available

Publication types